Alexander Augustyn, M.D., PH.D.

NPI 1265893184ActiveIndividual· Radiology, Radiation Oncology· Houston, TX

Radiology, Radiation Oncology (M.D., PH.D.) in Houston, Texas, trained at University of Texas Southwestern Medical School at Dallas (class of 2016). 214 Medicare patients in 2024, $185,469 paid; nearly all of their 301 Part D prescriptions were generic (99%). Pfizer Inc. was the largest of 2 companies reporting payments in 2025, $145.82 in all, mostly food and beverage.

Overview

NPI	1265893184
Status	Active
Entity type	Individual
Credential	M.D., PH.D.
Sole proprietor	No
NPI issued	Mar 20, 2016
Last updated in NPPES	May 5, 2025
Certified by provider	May 5, 2025

Specialties and licenses

Taxonomy	Code	License	State
Radiology, Radiation Oncology Primary	2085R0001X	01084669A	IN
Radiology, Radiation Oncology	2085R0001X	V6259	TX

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Radiation Oncology (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	214
Services billed	2,975 across 29 procedure codes
Paid by Medicare	$185,469

Part D prescriptions in 2024

Prescriptions (claims)	301 · 358 30-day fills
Patients	92
Total drug cost	$5,472
Generic share	99% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Southwestern Medical School at Dallas
Graduation year	2016
Medicare specialty	Radiation Oncology
Telehealth	Offers telehealth